New Published Findings in Med Establish Efficacy of Pangea Biomed’s ENLIGHT Platform

On December 12, 2023, Pangea Biomed announced that new findings establishing the efficacy of its novel ENLIGHT platform have been published in Med. The study, co-led by Pangea CTO Ranit Aharonov, PhD, and Eytan Ruppin, MD, PhD, Chief of the Cancer Data Science Lab at the NCI, reveals that ENLIGHT demonstrably enhances the ability to predict therapeutic response across multiple cancer types from the bulk tumor transcriptome. The Med article is titled “Clinically Oriented Prediction of Patient Response to Targeted and Immunotherapies from the Tumor Transcriptome.”